Junker Kerstin, Weirich Gregor, Amin Mahul B, Moravek Petr, Hindermann Winfried, Schubert Joerg
Department of Urology, Friedrich-Schiller University, 07743 Jena, Germany.
Recent Results Cancer Res. 2003;162:169-75. doi: 10.1007/978-3-642-59349-9_15.
The prognosis of renal cell carcinoma (RCC) varies dependent on histologic tumor subtypes. However, differentiation between RCC types may sometimes be difficult on histologic grounds alone. Furthermore, the prognostic value of histologic parameters for the individual prognosis is limited. Additional information on the molecular level seems necessary to obtain more certainty in diagnostic and prognostic evaluation. By investigating genetic alterations in different RCC subtypes, we sought to obtain a genotype-phenotype correlation. Eighty-two clear-cell, 53 papillary, 23 chromophobe RCCs and 26 renal oncocytomas were investigated. Comparative genomic hybridization (CGH) was performed on DNA from paraffin-embedded tissue samples. DNA was isolated from tumor areas by microdissection and amplified by degenerated oligonucleotide primed polymerase chain reaction (DOP-PCR). CGH was performed according to standard protocols. We were able to detect specific alterations in each RCC subtype: clear cell RCC showed -3p, +5/5q, -8p, -9, -14, -18; papillary (chromophilic) RCC gains of chromosomes 7, 17, 16, 3, 12; chromophobe RCC loss of chromosomes 1, 2, 6, 10, 13, 17, 21; renal oncocytomas loss of chromosomes 1/1p and 14. Furthermore, for clear cell RCC, it was possible to define alterations which are associated with metastatic disease: loss of 9, 10, 14. Our results demonstrate that each RCC subtype is characterized by distinct genetic alterations. The definition of genetic alterations seems helpful for a tumor typing especially when morphology is equivocal. Therefore, genetic analyses represent a powerful diagnostic and prognostic tool for RCC.
肾细胞癌(RCC)的预后因肿瘤组织学亚型而异。然而,有时仅基于组织学依据很难区分RCC的类型。此外,组织学参数对个体预后的预测价值有限。似乎有必要在分子水平上获取更多信息,以便在诊断和预后评估中获得更高的确定性。通过研究不同RCC亚型的基因改变,我们试图建立基因型与表型的相关性。我们研究了82例透明细胞型、53例乳头状、23例嫌色细胞型RCC以及26例肾嗜酸细胞瘤。对石蜡包埋组织样本的DNA进行了比较基因组杂交(CGH)分析。通过显微切割从肿瘤区域分离DNA,并通过简并寡核苷酸引物聚合酶链反应(DOP-PCR)进行扩增。CGH按照标准方案进行。我们能够在每种RCC亚型中检测到特定的改变:透明细胞RCC表现为-3p、+5/5q、-8p、-9、-14、-18;乳头状(嗜色性)RCC出现染色体7、17、16、3、12的增加;嫌色细胞RCC出现染色体1、2、6、10、13、17、21的缺失;肾嗜酸细胞瘤出现染色体1/1p和14的缺失。此外,对于透明细胞RCC,还可以确定与转移性疾病相关的改变:9、10、14号染色体的缺失。我们的结果表明,每种RCC亚型都具有独特的基因改变特征。基因改变的定义似乎有助于肿瘤分型,尤其是在形态学不明确的情况下。因此,基因分析是RCC强大的诊断和预后工具。